Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Conditions
Hematologic Malignancy · AML · ALL · BPDCN · MDS · Lymphoblastic Lymphoma · Lymphoma, B-Cell · Lymphoma, T-Cell · Hodgkin Lymphoma · Mixed Phenotype Acute Leukemia · Acute Undifferentiated Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Alan Wayne, MD)Children's Hospital Orange County, Orange, California, United States
Contact: Principal Investigator (Van Thu Huynh, MD)UCSF School of Medicine, San Francisco, California, United States
Contact: Principal Investigator (Michelle Hermiston, MD)Children's Hospital Colorado, Denver, Colorado, United States
Contact: Principal Investigator (Margaret Macy, MD)Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Reuven Schore, MD)University of Miami, Miami, Florida, United States
Contact: Study coordinator (Julio Barredo, MD)Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Melinda Pauly, MD)Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Jenna Rossoff, MD)Riley Hospital for Children, Indianapolis, Indiana, United States
Contact: Study coordinator (Sandeep Batra, MD)Johns Hopkins University, Baltimore, Maryland, United States
Contact: Principal Investigator (Pat Brown, MD)National Cancer Institute, Pediatric Oncology Branch, Bethesda, Maryland, United States
Contact: Principal Investigator (Nirali Shah, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Andrew Place, MD)C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Rajen Mody, MD)Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States
Contact: Study coordinator (Nathan Gossai, MD)Contact: Principal Investigator (Nathan Gossai, MD)Children's Hospital New York-Presbyterian, New York, New York, United States
Contact: Principal Investigator (Nobuko Hijiya, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Maria Sulis, MD, MS)Carolina-Levine Children's Hospital, Charlotte, North Carolina, United States
Contact: Principal Investigator (Joel Kaplan, MD)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Robin Norris, MD)Rainbow Babies, Cleveland, Ohio, United States
Contact: Principal Investigator (Rachel Egler, MD)Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Principal Investigator (Susan Vear-Colace, MD)Oregon Health & Science University, Portland, Oregon, United States
Contact: Principal Investigator (Bill Chang, MD)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Sue Rheingold, MD)St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Study coordinator (Jeffrey Rubnitz, MD)University of Texas, Southwestern, Dallas, Texas, United States
Contact: Study coordinator (Tamra Slone, MD)Cook Children's Hospital, Fort Worth, Texas, United States
Contact: Principal Investigator (Kenneth Heym, MD)Texas Children's Hospital/Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Eric Schafer, MD)Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Anupam Verma, MD)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Principal Investigator (Adam Lamble, MD)Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Zachary Graff, MD)Children's Hospital at Westmead, Westmead, New South Wales, Australia
Contact: Principal Investigator (Luciano Dalla-Pozza, MD)Sydney Children's Hospital, Sydney, Australia
Contact: Principal Investigator (Tracey O'Brien, MD)
Study leads
Adam Lamble, MD
Study Chair
Seattle Children's Hospital